BMC128 was developed by Biomica, Evogene’s subsidiary, and is currently completing Phase 1 clinical study, showing promising early clinical results ...
With plans for 25 international hubs, the Earth BioGenome Project is poised to increase global genomics capacity and deliver high-quality reference genomes, argues Dr Paul Flicek, The Jackson ...